The weaker affinity of this anti-CD3 domain permits serial engagement of CD8+ T cells regardless of their native antigen specificity, enabling recruitment of many more effector cells than are typically activated in the context of natural infection or therapeutic vaccination. This evidence concerns the gene CD8A and infection.